# DrDoctor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/drdoctor

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.drdoctor.co.uk
- Total disclosed funding: $16M
- Latest round: Series B (Feb 6, 2023)
- Investors on record: 3

## About

DrDoctor is a UK-based company that delivers innovative patient engagement solutions, facilitating efficient healthcare delivery through their unique platform. Their tools support hybrid healthcare environments, enhancing communication and coordination amongst patients and healthcare providers.Founded in 2012 in London, UK, DrDoctor specializes in patient engagement solutions through their platform, HybridOS. The company has undergone growth in its service offerings and focuses predominantly on the NHS. The founders include Perran Pengelly, Rinesh Amin, Thomas Whicher, and UHLich ELlenbee. The latest funding round was a Series B in February 2023, where DrDoctor raised GBP 10 million from lead investor YFM Equity Partners and returning investors Ananda Impact Ventures and 24Haymarket. The total amount raised by the company is GBP 10 million, with a current valuation of GBP 77.06 million.DrDoctor offers a comprehensive suite of patient engagement tools designed to enhance the delivery of hybrid healthcare. Their core platform, HybridOS, facilitates seamless care coordination by integrating automated scheduling, data-driven capacity controls, and tools for patient self-management. Key functionalities include appointment management, automated reminders, and real-time access to patient information, which collectively aim to reduce no-show rates and optimize clinic capacity. The products cater primarily to NHS hospitals and healthcare providers across the UK, serving over 35 million patients by enabling them to manage appointments, communicate with care teams, and access health information digitally.DrDoctor generates revenue through subscription-based models that target healthcare institutions, primarily NHS hospitals and associated healthcare providers. The company’s transactions typically involve long-term partnerships where healthcare organizations subscribe to the HybridOS platform for a fee, which grants them access to the suite of patient engagement tools. This structure allows hospitals to enhance operational efficiency and patient care while also securing a predictable revenue stream for DrDoctor. Their flagship services, including the Patient Engagement Platform and Care Hub, are geared towards creating digital transformation within the healthcare sector, focusing on patient empowerment and data-led decision-making.In February 2023, DrDoctor raised GBP 10 million in Series B funding, with plans to invest in product development and expand its presence throughout the NHS. The company aims to grow its sales and development teams to enhance service delivery and capture more market share in the UK healthcare sector.

## Funding rounds

- Series B, Feb 6, 2023, $12M — YFM Equity Partners, Ananda Impact Ventures, 24Haymarket
- Series A, Aug 21, 2020, $4M — Ananda Impact Ventures, 24Haymarket

## Investors

- Ananda Impact Ventures (https://capitalatlas.ai/funds/ananda-impact-ventures) — Series A, Series B
- 24Haymarket (https://capitalatlas.ai/funds/24haymarket) — Series A, Series B
- YFM Equity Partners (https://capitalatlas.ai/funds/yfm-equity-partners) — Series B